The use of this assay in clinical studies of diseases involving ECM remodeling might be useful to elucidate the role that biglycan exerts not only in the complex tissue environment during the pathological processes that cause RA and fibrosis, but also in other tissues where biglycan is expressed, such as muscle, bone, teeth and tendon. The gene discussed is BGN; the disease is rheumatoid arthritis.